Silverfin false 31/03/2023 01/04/2022 31/03/2023 Marley William Bates 21/01/2021 Philip Richard Bates 21/01/2021 24 November 2023 The principal activities of the Company during the financial year was that of providing consulting, development and coaching services. 13149256 2023-03-31 13149256 bus:Director1 2023-03-31 13149256 bus:Director2 2023-03-31 13149256 2022-03-31 13149256 core:CurrentFinancialInstruments 2023-03-31 13149256 core:CurrentFinancialInstruments 2022-03-31 13149256 core:ShareCapital 2023-03-31 13149256 core:ShareCapital 2022-03-31 13149256 core:RetainedEarningsAccumulatedLosses 2023-03-31 13149256 core:RetainedEarningsAccumulatedLosses 2022-03-31 13149256 core:ComputerEquipment 2022-03-31 13149256 core:ComputerEquipment 2023-03-31 13149256 bus:OrdinaryShareClass1 2023-03-31 13149256 2022-04-01 2023-03-31 13149256 bus:FullAccounts 2022-04-01 2023-03-31 13149256 bus:SmallEntities 2022-04-01 2023-03-31 13149256 bus:AuditExemptWithAccountantsReport 2022-04-01 2023-03-31 13149256 bus:PrivateLimitedCompanyLtd 2022-04-01 2023-03-31 13149256 bus:Director1 2022-04-01 2023-03-31 13149256 bus:Director2 2022-04-01 2023-03-31 13149256 1 2022-04-01 2023-03-31 13149256 core:ComputerEquipment core:TopRangeValue 2022-04-01 2023-03-31 13149256 2021-04-01 2022-03-31 13149256 core:ComputerEquipment 2022-04-01 2023-03-31 13149256 bus:OrdinaryShareClass1 2022-04-01 2023-03-31 13149256 bus:OrdinaryShareClass1 2021-04-01 2022-03-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: 13149256 (England and Wales)

REGENERATIVE TECHNOLOGIES LTD
(Formerly THE DIGITAL SCIENCE ACCELERATOR LTD)

Unaudited Financial Statements
For the financial year ended 31 March 2023
Pages for filing with the registrar

REGENERATIVE TECHNOLOGIES LTD

Unaudited Financial Statements

For the financial year ended 31 March 2023

Contents

REGENERATIVE TECHNOLOGIES LTD

STATEMENT OF FINANCIAL POSITION

As at 31 March 2023
REGENERATIVE TECHNOLOGIES LTD

STATEMENT OF FINANCIAL POSITION (continued)

As at 31 March 2023
Note 2023 2022
£ £
Fixed assets
Tangible assets 3 912 1,824
912 1,824
Current assets
Debtors 4 0 3,976
Cash at bank and in hand 10,634 22,072
10,634 26,048
Creditors: amounts falling due within one year 5 ( 20,083) ( 29,466)
Net current liabilities (9,449) (3,418)
Total assets less current liabilities (8,537) (1,594)
Net liabilities ( 8,537) ( 1,594)
Capital and reserves
Called-up share capital 6 1 1
Profit and loss account ( 8,538 ) ( 1,595 )
Total shareholder's deficit ( 8,537) ( 1,594)

For the financial year ending 31 March 2023 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Regenerative Technologies Ltd (registered number: 13149256) were approved and authorised for issue by the Director on 24 November 2023. They were signed on its behalf by:

Philip Richard Bates
Director
REGENERATIVE TECHNOLOGIES LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 March 2023
REGENERATIVE TECHNOLOGIES LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 March 2023
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial period, unless otherwise stated.

General information and basis of accounting

Regenerative Technologies Ltd (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is 1a Cotham Lawn Road, Bristol, BS6 6DU, England, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors have assessed the Statement of Financial Position and likely future cash flows at the date of approving these financial statements. The directors note that the business has net liabilities of £8,537. The Company is supported through loans from the directors. The directors have confirmed that the loan facilities will continue to be available for at least 12 months from the date of signing these financial statements and the directors will continue to support the Company. Given the current position, the directors believe that any foreseeable debts can be met for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Reporting period length

The financial statements for the comparative period are for a period of more than 12 months to align the period end with that preferred by the directors. The prior and current year figures are therefore not directly comparable.

Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Statement of Financial Position date.

Transition to FRS102

The Company has adopted FRS 102 for the year ended 31 March 2023, with the date of transition being 21 January 2021. No transitional adjustments are required.

Tangible fixed assets

Tangible fixed assets are stated at cost (or deemed cost) or valuation less accumulated depreciation and accumulated impairment losses. Cost includes costs directly attributable to making the asset capable of operating as intended. Depreciation is provided on all tangible fixed assets, other than investment properties and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a [straight-line/reducing balance] basis over its expected useful life, as follows:

Computer equipment 3 years straight line
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Government grants

Government grants are recognised based on the accrual model and are measured at the fair value of the asset received or receivable. Grants are classified as relating either to revenue or to assets. Grants relating to revenue are recognised in income over the period in which the related costs are recognised. Grants relating to assets are recognised over the expected useful life of the asset. Where part of a grant relating to an asset is deferred, it is recognised as deferred income.

Ordinary share capital

The ordinary share capital of the Company is presented as equity.

2. Employees

2023 2022
Number Number
Monthly average number of persons employed by the Company during the year, including directors 1 1

3. Tangible assets

Computer equipment Total
£ £
Cost
At 01 April 2022 2,736 2,736
At 31 March 2023 2,736 2,736
Accumulated depreciation
At 01 April 2022 912 912
Charge for the financial year 912 912
At 31 March 2023 1,824 1,824
Net book value
At 31 March 2023 912 912
At 31 March 2022 1,824 1,824

4. Debtors

2023 2022
£ £
Prepayments 0 3,976

5. Creditors: amounts falling due within one year

2023 2022
£ £
Amounts owed to directors 9,615 5,067
Accruals and deferred income 10,468 22,353
Other taxation and social security 0 2,046
20,083 29,466

6. Called-up share capital

2023 2022
£ £
Allotted, called-up and fully-paid
10,000 Ordinary shares of £ 0.0001 each 1 1

7. Related party transactions

At the balance sheet date and included within creditors are amounts totalling £9,615 (2022: £5,067) as due to the company directors. The loans are interest free and repayable on demand.